Abstract
Background and Aims: Insulin pumps, CGMs and glucose meters are now an integrated part of diabetes management. Most devices have their own software, and clinicians must switch between these during consultations. Our aim was to develop one platform for all diabetes device data independent of manufacturers.
Methods: Using the open source cloud‐based diabetes management software from Tidepool.org we developed a stand‐alone solution for all diabetes devices used at Steno Diabetes Center Copenhagen, providing service to more than 11.000 people with diabetes. The solution had to be customized to comply with GDPR regulations, hosted on an authorized server, have single sign‐on and user administration using Microsoft Active Directory, detailed logging of users and allow home‐based access and upload using the national login‐system available for all citizens in Denmark.
Results: As of November 2021, we started using the solution in the clinic, and continue further developments including closer integration with our electronic healthcare record (Epic, USA). People using different devices are now able to upload and access their own data in the same program, which also enables closer patient‐provider interaction as well as telemedicine consultations. Also, we are now able to collect continuous quality data, do clinical and real‐world evidence studies and start the development of more advanced use of diabetes data such as treatment guidance and alerts using AI technology.
Conclusions: By using open‐source software, it was feasible to create a single diabetes management platform for all diabetes devices data for benefit of people with diabetes, quality improvement.
Methods: Using the open source cloud‐based diabetes management software from Tidepool.org we developed a stand‐alone solution for all diabetes devices used at Steno Diabetes Center Copenhagen, providing service to more than 11.000 people with diabetes. The solution had to be customized to comply with GDPR regulations, hosted on an authorized server, have single sign‐on and user administration using Microsoft Active Directory, detailed logging of users and allow home‐based access and upload using the national login‐system available for all citizens in Denmark.
Results: As of November 2021, we started using the solution in the clinic, and continue further developments including closer integration with our electronic healthcare record (Epic, USA). People using different devices are now able to upload and access their own data in the same program, which also enables closer patient‐provider interaction as well as telemedicine consultations. Also, we are now able to collect continuous quality data, do clinical and real‐world evidence studies and start the development of more advanced use of diabetes data such as treatment guidance and alerts using AI technology.
Conclusions: By using open‐source software, it was feasible to create a single diabetes management platform for all diabetes devices data for benefit of people with diabetes, quality improvement.
Originalsprog | Engelsk |
---|---|
Artikelnummer | OP041 #220 |
Tidsskrift | Diabetes Technology & Therapeutics |
Vol/bind | 24 |
Udgave nummer | S1 |
ISSN | 1520-9156 |
Status | Udgivet - apr. 2022 |
Begivenhed | International Conference on Advanced Technologies and Treatments for Diabetes - Barcelona Varighed: 27 apr. 2022 → 30 apr. 2022 |
Konference
Konference | International Conference on Advanced Technologies and Treatments for Diabetes |
---|---|
By | Barcelona |
Periode | 27/04/2022 → 30/04/2022 |